Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer

Pyruvate kinase M2 (PKM2) regulates glycolysis and oxidative phosphorylation; however, the role of PKM2 in ovarian cancer remains largely unknown. We investigated whether ovarian cancer metabolism could provide insight into the development of therapeutic strategies. We performed immunohistochemical...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Chao, Tai-Kuang, Huang, Tien-Shuo, Liao, Yu-Ping, Huang, Rui-Lan, Su, Po-Hsuan, Shen, Hueng-Yuan, Lai, Hung-Cheng, Wang, Yu-Chi
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5533430/
https://ncbi.nlm.nih.gov/pubmed/28753677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0182166
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars